logo

For the Inventor, By the Inventor

Tustin, CA, United States of America

Peregrine Pharmaceuticals, Inc.


USPTO Granted Patents = 10

% Expired Patents = 40.0



Trademarks = 2

Forward Citations = 60

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Anita Kavlie (3 out of 20 patents)

silverMedal Kyle Schlunegger (3 out of 3 patents)

bronzeMedal Steven W King (3 out of 8 patents)

4.  Philip E Thorpe (2 out of 63 patents)

5.  Raimo Pellikka (2 out of 2 patents)

6.  Peter Bläuenstein (2 out of 2 patents)

7.  Pius A Schubiger (2 out of 2 patents)

8.  Yveta Germano (2 out of 2 patents)

9.  Shelley P M Fussey (1 out of 1 patent)

10.  Troy A Luster (1 out of 1 patent)

11.  Andrew James Williams (1 out of 6 patents)

12.  Philip Ronald Tempest (1 out of 19 patents)

13.  Thor Las Holtet (1 out of 2 patents)

14.  Helen Jackson (1 out of 2 patents)

15.  Alan J Schroit (1 out of 8 patents)


10 patents:

1. 9835626 - Methods and compositions for isolating exosomes (2017-12-05),
2. 9421256 - Anti-VEGF antibody compositions and methods (2016-08-23),
3. 8956616 - Constructs binding to phosphatidylserine and their use in disease treatment (2015-02-17),
4. 8394943 - Anti-VEGF antibody compositions and methods (2013-03-12),
5. 8137540 - Methods and apparatus for continuous large-scale radiolabeling (2012-03-20),
6. 8034905 - Anti-VEGF antibody compositions and methods (2011-10-11),
7. 7605234 - Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof (2009-10-20),
8. 7591953 - Methods and apparatus for continuous large-scale radiolabeling of proteins (2009-09-22),
9. 6255291 - Composition and method for treating cancer and immunological disorders resulting in chronic conditions (2001-07-03),
10. 5879880 - Method of diagnosing by determining formic acid to nicotinic acid ratio (1999-03-09),
Company Overview
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company based in Tustin, California, specializing in the development of innovative therapies for cancer and other serious diseases. The company focuses on advancing its proprietary technology platforms, which include monoclonal antibodies and other biologics, to enhance treatment efficacy and improve patient outcomes. With a commitment to scientific excellence, Peregrine aims to address unmet medical needs through its research initiatives and collaborations in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#15 in Tustin, CA

#7,118 in California

#29,882 in US

#56,092 in the World

Tustin, CA (US)
Tustin, CA, United States of America

Peregrine Pharmaceuticals, Inc.

Forward Citations = 60

17 inventors:

goldMedal Anita Kavlie (3 out of 20 patents)

silverMedal Kyle Schlunegger (3 out of 3 patents)

bronzeMedal Steven W King (3 out of 8 patents)

4.  Philip E Thorpe (2 out of 63 patents)

5.  Raimo Pellikka (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peregrine Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/peregrine-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…